CHA News Article

House Passes Bill to Address Drug Shortage

By a vote of 387-5, the U.S. House has passed its version of a bill to authorize user fees for the Food and Drug Administration (FDA). The bill will move to a conference committee to work out differences between it and a recently passed Senate bill (see  May 25 CHA News). While both bills contain CHA-supported provisions to mitigate the current drug shortage, the language in the House bill is slightly stronger. The House measure would impose fines on drug manufacturers who do not warn the FDA within six months of an anticipated drug shortage. The Senate bill would require manufacturers to participate in this early warning system but would not impose fines, making it essentially a voluntary program. CHA hopes the conference committee will strengthen drug shortage provisions in the final bill.